凱旺科技(301182.SZ):主要產品用於安防、通訊、消費電子的是精密線纜連接組件
格隆匯5月28日丨凱旺科技(301182.SZ)在投資者互動平台表示,公司的主要產品用於安防、通訊、消費電子的是精密線纜連接組件,公司目前的客户主要有海康威視、大華股份、宇視科技、中興通訊、立訊精密等國內安防、通訊、消費類電子產品的龍頭企業。消費類電子的具體應用場景中有應用到手機等各類電子產品的USB充電線,公司持續保持與客户的粘性,積極參與客户端新業務新產品的組件供應,具體消費類連接器是否已經運用到AI手機方面,因為大家對於AI 手機的定義和理解不同,請以公司的公開披露產品範圍為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.